Solid Tumor Combo1 EGFR ALK ROS1 MET PDL1 Test
Introduction
The Solid Tumor Combo1 EGFR ALK ROS1 MET PDL1 test is an essential diagnostic tool in oncology, designed to identify specific genetic mutations in tumor tissue. This test plays a crucial role in understanding the genetic makeup of solid tumors, which can significantly influence treatment decisions and patient outcomes. By pinpointing alterations in key genes, healthcare providers can tailor personalized treatment plans that enhance the effectiveness of therapies.
What the Test Measures
This test measures mutations in the following genes:
- EGFR (Epidermal Growth Factor Receptor)
- ALK (Anaplastic Lymphoma Kinase)
- ROS1 (ROS Proto-Oncogene 1)
- MET (Mesenchymal-Epithelial Transition Factor)
- PDL1 (Programmed Death-Ligand 1)
By analyzing these specific mutations, the test provides critical insights into the cancer’s behavior and potential response to targeted therapies.
Who Should Consider This Test?
Patients who should consider the Solid Tumor Combo1 test include:
- Individuals diagnosed with solid tumors.
- Patients with a family history of cancer.
- Those experiencing symptoms such as unexplained weight loss, persistent cough, or unusual growths.
- Patients seeking personalized treatment options based on genetic profiling.
Benefits of Taking the Test
Taking the Solid Tumor Combo1 test offers several benefits:
- Identifies specific mutations that can affect treatment choices.
- Helps in selecting targeted therapies that may be more effective for the patient.
- Provides insights into prognosis and potential disease progression.
- Facilitates informed discussions between patients and healthcare providers regarding treatment options.
Understanding Your Results
Results from the Solid Tumor Combo1 test typically take 5-7 days to process. Understanding these results is crucial for making informed treatment decisions. A healthcare provider will explain the significance of any identified mutations and how they may influence therapy options.
Test Name and Price
| Test Name | Discount Price | Regular Price |
|---|---|---|
| Solid Tumor Combo1 EGFR ALK ROS1 MET PDL1 | 750,000 NGN | 1,000,000 NGN |
Booking the Test
To book the Solid Tumor Combo1 EGFR ALK ROS1 MET PDL1 test, please ensure you have a Doctor’s prescription. Note that this prescription is not applicable for surgery, pregnancy cases, or individuals planning to travel abroad. For more information or to schedule your test, call or WhatsApp us at +2348077798758.
